To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC47559 | Dihydroevocarpine |
Dihydroevocarpine induces cytotoxicity in acute myeloid leukemia via suppressing the mTORC1/2 activity.
More description
|
|
| DC47555 | CP-601932 |
CP-601932 ((1S,5R)-CP-601927) is a high-affinity partial agonist at α3β4 nAChR (EC50=~ 3 μM). CP-601932 has the same high-binding affinity at α3β4 (Ki=21 nM) as at α4β2 nAChRs (Ki=21 nM) and an order of magnitude lower affinity for α6 and α7 nAChR subtypes. CP-601932 selectively decreases ethanol but not sucrose consumption and operant self-administration following long-term exposure. CP-601932 readily penetrates the CNS.
More description
|
|
| DC47551 | IMD-vanillin |
IMD-vanillin is a novel imidazoquinolinone-NF-κB immunomodulator dimers.
More description
|
|
| DC47550 | HE 3286 |
HE3286, a synthetic derivative of the adrenal steroid β-AET, is an orally-active partially NF-κB inhibitor.
More description
|
|
| DC47549 | IMD-biphenylA |
IMD-biphenylA is a novel imidazoquinolinone-NF-κB immunomodulator dimer that improves the adjuvanticity of small molecule immune potentiators.
More description
|
|
| DC47548 | IMD-ferulic |
IMD-ferulic is a covalently linked NF-κB modulator that improves the adjuvanticity of small molecule immune potentiators.
More description
|
|
| DC47545 | IMD-biphenylC |
IMD-biphenylC is a novel imidazoquinolinone-NF-κB immunomodulator dimer that inhibits tumor proliferation while induces low systemic inflammation and reduces adjuvant toxicity.
More description
|
|
| DC47544 | IMD-catechol |
IMD-catechol is a novel imidazoquinolinone-NF-κB immunomodulator dimer that improves efficacy in a CT26 mouse colon carcinoma tumor model while eliciting minimal adjuvant toxicity.
More description
|
|
| DC47543 | FeTPPS |
FeTPPS, a 5,10,15,20-tetrakis (4-sulfonatophenyl) porphyrin iron III chloride peroxynitrite decomposition catalyst, possessed evident neuroprotective effects in a experimental model of spinal cord damage. FeTPPS acts as a peroxynitrite scavenger and anti-nitrating agent in vivo. FeTPPS reduces nitric oxide (NO) production and apoptosis process.
More description
|
|
| DC47528 | Compound 48/80 |
Compound 48/80 (Poly-p-methoxyphenethylmethylamine) is widely used in animal and tissue models as a "selective" mast cell activator. Compound 48/80 acts at the mast cell membrane to stimulate trimeric G-proteins and induces degranulation via phospholipase C and D pathways.
More description
|
|
| DC47524 | Idroxioleic acid |
Idroxioleic acid ((R)-2-Hydroxyoleic acid; (R)-2-OHOA), the R enantiomer of (Rac)-Idroxioleic acid, is an orally active fatty acid that modulates the lipid composition and structure of the membranes. Idroxioleic acid has antitumor activities.
More description
|
|
| DC47523 | D-threo-PPMP |
D-threo-PPMP is a potent inhibitor of glucosylceramide (GlcCer) synthase. D-threo-PPMP can block karyokinesis and reduce cyst production.
More description
|
|
| DC47513 | ERGi-USU-6 mesylate |
ERGi-USU-6 (mesylate) is an ERGi-USU-6 salt derivative that is a new selective inhibitor of ERG positive prostate cancer ( IC50 = 0.089 μM).
More description
|
|
| DC47511 | gTPA2-OMe |
gTPA2-OMe is a potential hole transport layer candidate for perovskite solar cells (PSCs).
More description
|
|
| DC47509 | Antiviral agent 6 |
Antiviral agent 6 shows excellent anti-TSWV activity in vivo, and the EC50 value is 188 mg/L.
More description
|
|
| DC47504 | Anti-ToCV agent 1 |
Anti-ToCV agent 1 can be used as a potential anti-ToCV drug.
More description
|
|
| DC47503 | Antiviral agent 7 |
Antiviral agent 7 is a peptide-based coating that can kill viruses.
More description
|
|
| DC47502 | APJ receptor agonist 3 |
APJ receptor agonist 3 is a potent and orally active APJ receptor agonist with an EC50 value of 0.027 nM.
More description
|
|
| DC47501 | Cyclopropenone probe 1 |
Cyclopropenone probe 1 can specifically and efficiently modify a triple-negative breast cancer driver, glutathione S-transferase pi-1 (GSTP1), by covalently binding at the catalytic active site.
More description
|
|
| DC47500 | FTO-IN-4 |
FTO-IN-4 is a potent and selective inhibitor of fat mass obesity-associated protein (FTO).
More description
|
|
| DC47499 | FTO-IN-5 |
FTO-IN-5 is a potent and selective inhibitor of fat mass obesity-associated protein (FTO).
More description
|
|
| DC47498 | hTrkA-IN-2 |
hTrkA-IN-2 is a selective hTrkA allosteric inhibitor with an IC50 value of 3.9 nM.
More description
|
|
| DC47489 | Antitumor agent-29 |
Antitumor agent-29 is a novel hepatocyte-targeting antitumor prodrug, which exhibits good antitumor activity and low toxic side effects.
More description
|
|
| DC47488 | DN-F01 |
DN-F01 has a strong inhibitory calcium-dependent effect on cardiac myofibrillar ATPase activity with an IC50 value of 11 ± 4 nmol/L.
More description
|
|
| DC47487 | Epyrifenacil |
Epyrifenacil is a newly developed herbicide.
More description
|
|
| DC47486 | Galectin-8-IN-1 |
Galectin-8-IN-1 is a selective ligand for the galectin-8 N-terminal domain (galectin-8N), with a Kd of 48 μM and 15-fold selectivity over galectin-3 and even better selectivity over the other mammalian galectins.
More description
|
|
| DC47480 | GT-055 |
GT-055 (LCB18-055) is a novel broad-spectrum β-lactamase inhibitor.
More description
|
|
| DC47479 | CASK-IN-1 |
CASK-IN-1 is a highly potent and selective CASK inhibitor with a Kd value of 0.022 μM.
More description
|
|
| DC47477 | Anti-TSWV agent 1 |
Anti-TSWV agent 1 exhibits excellent inactivation activity against tomato spotted wilt virus (TSWV), with an EC50 value of 144 μg/mL.
More description
|
|
| DC47475 | eeAChE-IN-1 |
eeAChE-IN-1 is a potent eeAChE inhibitor with an IC50 value of 23 nM.
More description
|
|